A Brain on Cannabinoids: The Role of Dopamine Release in Reward Seeking
Authors:
Open Access
- 1 August 2012
- journal article
- review article
- Published by Cold Spring Harbor Laboratory in Cold Spring Harbor Perspectives in Medicine
- Vol. 2 (8) , a012229
Abstract
Increases in mesolimbic dopamine transmission are observed when animals are treated with all known drugs of abuse, including cannabis, and to conditioned stimuli predicting their availability. In contrast, decreases in mesolimbic dopamine function are observed during drug withdrawal, including cannabis-withdrawal syndrome. Thus, despite general misconceptions that cannabis is unique from other drugs of abuse, cannabis exerts identical effects on the mesolimbic dopamine system. The recent discovery that endogenous cannabinoids modulate the mesolimbic dopamine system, however, might be exploited for the development of potential pharmacotherapies designed to treat disorders of motivation. Indeed, disrupting endocannabinoid signaling decreases drug-induced increases in dopamine release in addition to dopamine concentrations evoked by conditioned stimuli during reward seeking.Keywords
This publication has 82 references indexed in Scilit:
- Endocannabinoids Shape Accumbal Encoding of Cue-Motivated Behavior via CB1 Receptor Activation in the Ventral TegmentumNeuron, 2012
- Supply and demand for endocannabinoidsTrends in Neurosciences, 2011
- Neural encoding of cocaine‐seeking behavior is coincident with phasic dopamine release in the accumbens core and shellEuropean Journal of Neuroscience, 2009
- Drug Addiction2009
- Neurobiological substrates for the dark side of compulsivity in addictionNeuropharmacology, 2009
- Dissecting motivational circuitry to understand substance abuseNeuropharmacology, 2009
- The endocannabinoid system in brain reward processesBritish Journal of Pharmacology, 2008
- Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist RimonabantNeuropsychopharmacology, 2008
- The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibitionNeuropharmacology, 2008
- Toward a model of drug relapse: an assessment of the validity of the reinstatement procedurePsychopharmacology, 2006